Frost Gamma Investments Trust → Cocrystal Pharma, Inc. COCP

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100

Passive Schedule 13G filer baseline
Moderate short days-to-cover (4.9 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.89

179,193 shares short · +2.3% vs prior

Other 13D/G Filings on Cocrystal Pharma, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-07	SCHEDULE 13D/A	FROST PHILLIP MD ET AL	13.90%	2,784,719	view →
2026-08-07	SCHEDULE 13D	OPKO HEALTH, INC.	29.60%	5,692,916	view →
2024-01-02	SC	SABBY MANAGEMENT, LLC	—	—	view →
2021-06-10	SC	FROST PHILLIP MD ET AL	—	—	view →
2020-11-19	SC	OPKO HEALTH, INC.	—	—	view →
2020-03-10	SC	Opko Health, Inc.	—	—	view →
2019-11-22	SC	Opko Health, Inc.	—	—	view →

Other Filings by Frost Gamma Investments Trust

Filed	Form	Issuer	Stake	Shares
2019-02-14	SC	BioCardia, Inc. BCDA	—	—	view →
2019-01-11	SC	BioCardia, Inc. BCDA	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →